Delivery Order SPE2DB20D7061-SPE2DB24FSLZ0
Award Date 1/2/24
Potential Completion Date 1/3/24
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,308.99, is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price Delivery Order with a performance period ending on January 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,393.52, is for the supply of XIFAXAN 550 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $79,753.90, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of May 21, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,518.61 firm fixed-price contract is for the supply of XIFAXAN 550 MG TABLET UD 60S, a pharmaceutical product. The contract has a period of performance through November 5, 2024 and was awarded on November 4, 2022. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $88,019.10, is for the supply of XIFAXAN 550 MG Tablets, a prescription medication. The contract has an ultimate completion date of February 14, 2025 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
- This is a $6,318.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a medication, with a period of performance through June 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a prescription medication. The contract has a firm fixed price with a ceiling value of $15,346.17 and an ultimate completion date of June 18, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,931.33 and is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and a performance period through November 6, 2023. This order is associated with a larger Indefinite Delivery Contract (IDC) that...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $67,137.25 contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of June 17, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,614.33, is for the delivery of XIFAXAN 550 MG TABLET UD 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of February 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...